The checkpoint inhibitor TIGIT limits antitumor and antiviral CD8+ T cell responses

OncoImmunology

Volumn 4, Issue 9, 2015, Pages 1-2

  Johnston, Robert J ^a   Yu, Xin ^a   Grogan, Jane L ^a  

^a GENENTECH INC   (United States)

Author keywords

Antibodies; Cancer immunotherapy; CD226; PD1; TIGIT; Virus

Indexed keywords

CHECKPOINT KINASE INHIBITOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR; TIGIT RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; NONHUMAN; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; TUMOR REJECTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

EID: 84944446213     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1036214     Document Type: Article

References (10)

1. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439:682-7; PMID:16382236; http://dx.doi.org/10.1038/nature04444
2. Johnston RJ, Comps-Agrar L, Hackney J, Yu X, Huseni M, Yang Y, Park S, Javinal V, Chiu H, Irving B et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell 2014; 26:923-37; PMID:25465800; http://dx.doi. org/10.1016/j.ccell.2014.10.018
3. Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, Tom I, Ivelja S, Refino CJ, Clark H et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 2009; 10:48-57; PMID:19011627; http://dx.doi.org/10.1038/ni.1674
4. Stengel KF, Harden-Bowles K, Yu X, Rouge L, Yin J, Comps-Agrar L, Wiesmann C, Bazan JF, Eaton DL, Grogan JL. Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering. Proc Natl Acad Sci U S A 2012; 109:5399-404; PMID:22421438; http://dx.doi.org/ 10.1073/pnas.1120606109
5. Stanietsky N, Simic H, Arapovic J, Toporik A, Levy O, Novik A, Levine Z, Beiman M, Dassa L, Achdout H et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc Natl Acad Sci U S A 2009; 106:17858-63; PMID:19815499; http://dx.doi.org/10.1073/pnas.0903474106
6. Levin SD, TaftDW, Brandt CS, Bucher C, Howard ED, Chadwick EM, Johnston J, Hammond A, Bontadelli K, ArdourelD et al. Vstm3 is a member of the CD28 family and an important modulator of T-cell function. Eur J Immunol 2011; 41:902-15; PMID:21416464; http://dx. doi.org/10.1002/eji.201041136
7. Joller N, Lozano E, Burkett PR, Patel B, Xiao S, Zhu C, Xia J, Tan TG, Sefik E, Yajnik V et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 2014; 40:569-81; PMID:24745333; http:// dx.doi.org/10.1016/j.immuni.2014.02.012
8. Lozano E, Dominguez-Villar M, Kuchroo V, Hafler DA. The TIGIT/CD226 axis regulates human T cell function. J Immunol 2012; 188:3869-75; PMID:22427644; http://dx.doi.org/10.4049/jimmunol.1103627
9. Li M, Xia P, Du Y, Liu S, Huang G, Chen J, Zhang H, Hou N, Cheng X, Zhou L et al. T-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-gamma production of natural killer cells via betaarrestin 2-mediated negative signaling. JBiol Chem 2014; 289:17647-57; PMID:24817116; http://dx.doi. org/10.1074/jbc.M114.572420
10. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, Khoury SJ, Zheng XX, Strom TB, Kuchroo VK. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005; 6:1245-52; PMID:16286920; http://dx.doi. org/10.1038/ni1271